Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Stuver

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Frontiers in Immunology|October 23, 2023
Advances in the treatment of mycoses fungoides and Sézary syndrome: a narrative update in skin-directed therapies and immune-based treatmentsRobert Stuver, Shamir Geller
Hematology. American Society of Hematology. Education Program|December 7, 2024
Through thick and thin: confronting the aggressive cutaneous T-cell lymphomasRobert Stuver, Steven M Horwitz
Cancers|February 11, 2023
Therapeutic Advances in Relapsed and Refractory Peripheral T-Cell LymphomaRobert Stuver, Alison J Moskowitz
International Journal of Hematology|December 27, 2022
Moving towards biologically informed treatment strategies for T-cell lymphomasRobert Stuver, Natasha Lewis, Ahmet Dogan, et al.
Haematologica|December 1, 2023
Few and far between: clinical management of rare extranodal subtypes of mature T-cell and NK-cell lymphomasRobert Stuver, Zachary D Epstein-Peterson, Steven M Horwitz
Current Treatment Options in Oncology|June 10, 2023
Treatment of Adult T-Cell Leukemia/Lymphoma: Established Paradigms and Emerging DirectionsRobert Stuver, Steven M Horwitz, Zachary D Epstein-Peterson
Case Reports in Hematology|October 23, 2018
Multiple Myeloma Masquerading as Ovarian Carcinosarcoma Metastases: A Case Report and Review of the Approach to Multiple Myeloma Screening and DiagnosisRobert Stuver, Alec Petersen, Thomas A Guerrero-Garcia, et al.
Critical Reviews in Oncology/Hematology|September 7, 2024
Management of peripheral neuropathy associated with brentuximab vedotin in the frontline treatment of classical Hodgkin lymphomaJeremy S Abramson, Robert Stuver, Alex Herrera, et al.
JCO Oncology Practice|July 30, 2020
Survivorship Care Plans: Reaching a Benchmark and Striving to Achieve IntentRobert Stuver, Jennifer Faig, Matthew Cadorette, et al.
Oncology (Williston Park, N.Y.)|May 16, 2022
Current Treatment of Peripheral T-cell LymphomaRobert Stuver, Zachary D Epstein-Peterson, William T Johnson, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|October 23, 2023
Advances in the treatment of mycoses fungoides and Sézary syndrome: a narrative update in skin-directed therapies and immune-based treatmentsRobert Stuver, Shamir Geller
Hematology. American Society of Hematology. Education Program|December 7, 2024
Through thick and thin: confronting the aggressive cutaneous T-cell lymphomasRobert Stuver, Steven M Horwitz
Cancers|February 11, 2023
Therapeutic Advances in Relapsed and Refractory Peripheral T-Cell LymphomaRobert Stuver, Alison J Moskowitz
International Journal of Hematology|December 27, 2022
Moving towards biologically informed treatment strategies for T-cell lymphomasRobert Stuver, Natasha Lewis, Ahmet Dogan, et al.
Haematologica|December 1, 2023
Few and far between: clinical management of rare extranodal subtypes of mature T-cell and NK-cell lymphomasRobert Stuver, Zachary D Epstein-Peterson, Steven M Horwitz
Current Treatment Options in Oncology|June 10, 2023
Treatment of Adult T-Cell Leukemia/Lymphoma: Established Paradigms and Emerging DirectionsRobert Stuver, Steven M Horwitz, Zachary D Epstein-Peterson
Case Reports in Hematology|October 23, 2018
Multiple Myeloma Masquerading as Ovarian Carcinosarcoma Metastases: A Case Report and Review of the Approach to Multiple Myeloma Screening and DiagnosisRobert Stuver, Alec Petersen, Thomas A Guerrero-Garcia, et al.
Critical Reviews in Oncology/Hematology|September 7, 2024
Management of peripheral neuropathy associated with brentuximab vedotin in the frontline treatment of classical Hodgkin lymphomaJeremy S Abramson, Robert Stuver, Alex Herrera, et al.
JCO Oncology Practice|July 30, 2020
Survivorship Care Plans: Reaching a Benchmark and Striving to Achieve IntentRobert Stuver, Jennifer Faig, Matthew Cadorette, et al.
Oncology (Williston Park, N.Y.)|May 16, 2022
Current Treatment of Peripheral T-cell LymphomaRobert Stuver, Zachary D Epstein-Peterson, William T Johnson, et al.
Pageof 3